Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Lupus
|
September 18, 2014
Recurrent early pregnancy loss and antiphospholipid antibodies: where do we stand?
L F Wong, T F Porter, G R de Jesús
BJOG : an International Journal of Obstetrics and Gynaecology
|
February 5, 2009
Optimal management strategies for placenta accreta
A G Eller, T F Porter, P Soisson, et al.
British Journal of Pharmacology
|
May 9, 2009
Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress
M Spite, L Summers, T F Porter, et al.
The Journal of Allergy and Clinical Immunology
|
October 5, 2001
Obstetric uses of intravenous immunoglobulin: successes, failures, and promises
D W Branch, T F Porter, M J Paidas, et al.
Obstetrics and Gynecology
|
May 1, 1996
Normal values for amniotic fluid index during uncomplicated twin pregnancy
T F Porter, G A Dildy, J R Blanchard, et al.
American Journal of Obstetrics and Gynecology
|
April 1, 1995
Amniotic fluid embolism: analysis of the national registry
S L Clark, G D Hankins, D A Dudley, et al.
Obstetrics and Gynecology
|
July 1, 1997
The risk of preterm birth across generations
T F Porter, A M Fraser, C Y Hunter, et al.
American Journal of Obstetrics and Gynecology
|
May 20, 2000
Neonatal alloimmune thrombocytopenia: antenatal management
R M Silver, T F Porter, D W Branch, et al.
Obstetrical & Gynecological Survey
|
March 1, 1997
Intravenous immune globulin in the management of severe Rh D hemolytic disease
T F Porter, R M Silver, G M Jackson, et al.
American Journal of Obstetrics and Gynecology
|
March 30, 2000
Is vaginal birth after cesarean less expensive than repeat cesarean delivery?
S L Clark, J R Scott, T F Porter, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Lupus
|
September 18, 2014
Recurrent early pregnancy loss and antiphospholipid antibodies: where do we stand?
L F Wong, T F Porter, G R de Jesús
BJOG : an International Journal of Obstetrics and Gynaecology
|
February 5, 2009
Optimal management strategies for placenta accreta
A G Eller, T F Porter, P Soisson, et al.
British Journal of Pharmacology
|
May 9, 2009
Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress
M Spite, L Summers, T F Porter, et al.
The Journal of Allergy and Clinical Immunology
|
October 5, 2001
Obstetric uses of intravenous immunoglobulin: successes, failures, and promises
D W Branch, T F Porter, M J Paidas, et al.
Obstetrics and Gynecology
|
May 1, 1996
Normal values for amniotic fluid index during uncomplicated twin pregnancy
T F Porter, G A Dildy, J R Blanchard, et al.
American Journal of Obstetrics and Gynecology
|
April 1, 1995
Amniotic fluid embolism: analysis of the national registry
S L Clark, G D Hankins, D A Dudley, et al.
Obstetrics and Gynecology
|
July 1, 1997
The risk of preterm birth across generations
T F Porter, A M Fraser, C Y Hunter, et al.
American Journal of Obstetrics and Gynecology
|
May 20, 2000
Neonatal alloimmune thrombocytopenia: antenatal management
R M Silver, T F Porter, D W Branch, et al.
Obstetrical & Gynecological Survey
|
March 1, 1997
Intravenous immune globulin in the management of severe Rh D hemolytic disease
T F Porter, R M Silver, G M Jackson, et al.
American Journal of Obstetrics and Gynecology
|
March 30, 2000
Is vaginal birth after cesarean less expensive than repeat cesarean delivery?
S L Clark, J R Scott, T F Porter, et al.
Page
of 3